Nexien Biopharma Stock Price, News & Analysis
Company Description
Nexien Biopharma (OTC Link: NXEN) is a publicly traded drug manufacturers - specialty & generic company in the Healthcare sector. The company has a market capitalization of $7.1K.
NXEN stock has declined 99.3% over the past year. Shares last traded at $0.0001.
On a trailing twelve-month basis, Nexien Biopharma and diluted earnings per share of $0.00.
This page provides a comprehensive overview of NXEN stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Nexien Biopharma (NXEN) stock last traded at $0.0001. Over the past 12 months, the stock has lost 99.3%. At a market capitalization of $7.1K, NXEN is classified as a micro-cap stock with approximately 70.8M shares outstanding.
Latest News
Nexien Biopharma has 1 recent news article. Of the recent coverage, 1 article coincided with positive price movement and 0 with negative movement. View all NXEN news →
SEC Filings
Nexien Biopharma has filed 2 recent SEC filings, including 2 Form 15-12G. The most recent filing was submitted on September 19, 2025. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all NXEN SEC filings →
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
NXEN Company Profile & Sector Positioning
Nexien Biopharma (NXEN) operates in the Drug Manufacturers - Specialty & Generic industry within the broader Healthcare sector and is listed on the OTC Link.
Investors comparing NXEN often look at related companies in the same sector, including Adastra Holdings Ltd (XTXXF), Rimrock Gold (RMRK), Kaya Hldgs Inc (KAYS), Pharmadrug Inc (LMLLF), and Cann American Corp (CNNA). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate NXEN's relative position within its industry.